Upon exposure to pathogens or damaged tissue, they mature, reduce antigen uptake, upregulate MHC-II and CCR7, and migrate to LN, driving T-cell responses through TNF-α, IL-12, IL-6, and IL-8 secretion, improving cancer treatment outcomes (49, 50). Here, IL6 is linked to cancer.